These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11187651)

  • 41. Incorporating evaluation into the design of a decision-support system.
    Visscher S; Schurink K; Bonten M; Lucas P; Van Wolffelaar J; Van de Werken P
    Stud Health Technol Inform; 2004; 110():54-60. PubMed ID: 15853252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005.
    Moore TJ; Cohen MR; Furberg CD
    Arch Intern Med; 2007 Sep; 167(16):1752-9. PubMed ID: 17846394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Case-based reasoning for medical knowledge-based systems.
    Schmidt R; Gierl L
    Stud Health Technol Inform; 2000; 77():720-5. PubMed ID: 11187647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The CAREPLAN knowledge base. A prototype expert system for postpartum nursing care.
    Probst CL; Rush J
    Comput Nurs; 1990; 8(5):206-13. PubMed ID: 2224637
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The potential for intelligent decision support systems to improve the quality and consistency of medication reviews.
    Bindoff I; Stafford A; Peterson G; Kang BH; Tenni P
    J Clin Pharm Ther; 2012 Aug; 37(4):452-8. PubMed ID: 22175237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An incremental knowledge acquisition-based system for supporting decisions in biomedical domains.
    Torralba-Rodríguez FJ; Bixquert-Montagud V; Fernández-Breis JT; Martínez-Béjar R
    Comput Methods Programs Biomed; 2010 May; 98(2):161-71. PubMed ID: 20004039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toward automatic detection and prevention of adverse drug events.
    Leroy N; Chazard E; Beuscart R; Beuscart-Zephir MC;
    Stud Health Technol Inform; 2009; 143():30-5. PubMed ID: 19380911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System).
    Guzek M; Zorina OI; Semmler A; Gonzenbach RR; Huber M; Kullak-Ublick GA; Weller M; Russmann S
    Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):930-8. PubMed ID: 21774031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-induced disorders.
    Holland EG; Degruy FV
    Am Fam Physician; 1997 Nov; 56(7):1781-8, 1791-2. PubMed ID: 9371009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using computer technology to detect, measure, and prevent adverse drug events.
    Gardner RM; Evans RS
    J Am Med Inform Assoc; 2004; 11(6):535-6. PubMed ID: 15317740
    [No Abstract]   [Full Text] [Related]  

  • 51. Reduction of adverse drug reactions by computerized drug interaction screening.
    Davidson KW; Kahn A; Price RD
    J Fam Pract; 1987 Oct; 25(4):371-5. PubMed ID: 3655673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adverse drug events prevention rules: multi-site evaluation of rules from various sources.
    Chazard E; Ficheur G; Merlin B; Serrot E; ; Beuscart R
    Stud Health Technol Inform; 2009; 148():102-11. PubMed ID: 19745240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Designing a tool to describe drug interactions and adverse events for learning and clinical routine].
    Auzéric M; Bellemère J; Conort O; Roubille R; Allenet B; Bedouch P; Rose FX; Juste M; Charpiat B
    Ann Pharm Fr; 2009 Nov; 67(6):433-41. PubMed ID: 19900608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [An expert clinical diagnosis system for the support of the primary consultation].
    Rozenbojm J; Palladino E; Azevedo AC
    Salud Publica Mex; 1993; 35(3):321-5. PubMed ID: 8322110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A knowledge engineering framework towards clinical support for adverse drug event prevention: the PSIP approach.
    Koutkias V; Stalidis G; Chouvarda I; Lazou K; Kilintzis V; Maglaveras N
    Stud Health Technol Inform; 2009; 148():131-41. PubMed ID: 19745243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Data mining to generate adverse drug events detection rules.
    Chazard E; Ficheur G; Bernonville S; Luyckx M; Beuscart R
    IEEE Trans Inf Technol Biomed; 2011 Nov; 15(6):823-30. PubMed ID: 21859604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Towards a standardised representation of a knowledge base for adverse drug event prevention.
    Koutkias V; Lazou K; de Clercq P; Maglaveras N
    Stud Health Technol Inform; 2011; 166():139-47. PubMed ID: 21685619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expert systems.
    Morrell R; Wasilauskas B; Winslow R
    Am J Hosp Pharm; 1994 Aug; 51(16):2022-30; quiz 2045-6. PubMed ID: 7977423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparative study of an expert system application in the prescription of medications].
    Codina C; Corominas N; Roca M; Tuset M; del Cacho E; Soy D; Gómez B; Pérez M; Massó J; Ribas J
    Med Clin (Barc); 1997 Oct; 109(14):538-41. PubMed ID: 9508614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prescription guidelines in OPADE: what are they, how are they used?
    de Zegher I; Milstein C; Séné B; Venot A
    Stud Health Technol Inform; 1995; 16():199-205. PubMed ID: 10163715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.